Skip to main content

Great Myths of Blood Pressure Effect Size in Renal Denervation

  • Chapter
  • First Online:
Renal Denervation

Abstract

False.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Howard JP, Nowbar AN, Francis DP. Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report. Heart. 2013;99:1579–87.

    Article  PubMed  Google Scholar 

  2. American Heart Association. Methodology manual and policies from the ACCF/AHA Task Force on practice guidelines. 2010;65.

    Google Scholar 

  3. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19:243–50.

    Article  PubMed  Google Scholar 

  4. Verdecchia P, Reboldi G, Porcellati C, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol. 2002;39:878–85.

    Article  PubMed  Google Scholar 

  5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.

    Article  PubMed  Google Scholar 

  6. Warren RE, Marshall T, Padfield PL, Chrubasik S. Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract. 2010;60:675–80.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004;22:435–45.

    Article  CAS  PubMed  Google Scholar 

  8. O’Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ. 2000;320:1128–34.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Mahfoud F, Ukena C, Schmieder RE, et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013;128:132–40.

    Article  CAS  PubMed  Google Scholar 

  10. Simonetti G, Spinelli A, Gandini R, et al. Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience. Radiol Med. 2012;117:426–44.

    Article  CAS  PubMed  Google Scholar 

  11. Deflating the hype: are we setting renal denervation up for disappointment? 2013. At http://www.massdevice.com/features/deflating-hype-are-we-setting-renal-denervation-disappointment.

  12. Indiana Pi Bill. At http://en.wikipedia.org/wiki/Indiana_Pi_Bill.

  13. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. St. Jude Medical EnligHTNment Study Highlighted at EuroPCR during trials that may change clinical practice session. 2013. At http://www.sjm.com/corporate/media-room/media-kits/new-products/~/media/SJM/corporate/Media%20Kits/EnligHTN/for_05212013/052113EnligHTNmentNewsReleaseFINAL.ashx.

  15. Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126:2976–82.

    Article  CAS  PubMed  Google Scholar 

  16. Worthley SG, Tsioufis CP, Worthley MI, et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J. 2013;34:2132–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Darrel P. Francis MA, MB BChir, FRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Howard, J.P., Shun-Shin, M.J., Francis, D.P. (2015). Great Myths of Blood Pressure Effect Size in Renal Denervation. In: Heuser, R., Schlaich, M., Sievert, H. (eds) Renal Denervation. Springer, London. https://doi.org/10.1007/978-1-4471-5223-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5223-1_21

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5222-4

  • Online ISBN: 978-1-4471-5223-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics